{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:43:19Z","timestamp":1793965399902,"version":"4.8.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.vaccine.2016.08.085","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T17:50:20Z","timestamp":1476899420000},"page":"5708-5723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":243,"title":["Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"34","author":[{"given":"J.E.","family":"Isenor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.T.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Alia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Slayter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"MacDougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.085_b0005","unstructured":"World Health Organization (WHO). Immunization. <http:\/\/www.who.int\/topics\/immunization\/en\/> [accessed 13.08.15]."},{"key":"10.1016\/j.vaccine.2016.08.085_b0010","unstructured":"U.S. Department of Health & Human Services. 2010 National vaccine plan. <http:\/\/www.hhs.gov\/nvpo\/vacc_plan\/>; 2015 [accessed 16.06.24]."},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.085_b0015","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1331\/JAPhA.2011.11544","article-title":"Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA\/AMCP stakeholder meeting","volume":"51","author":"Skelton","year":"2011","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.vaccine.2016.08.085_b0020","unstructured":"World Health Organization (WHO). What are some of the myths and facts about vaccination? <http:\/\/www.who.int\/features\/qa\/84\/en\/> [accessed 16.05.27]."},{"key":"10.1016\/j.vaccine.2016.08.085_b0025","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1016\/j.vaccine.2009.04.055","article-title":"Alternative vaccination locations: who uses them and can they increase flu vaccination rates?","volume":"27","author":"Lee","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.085_b0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1478-7547-10-10","article-title":"Planning influenza vaccination programs: a cost benefit model","volume":"10","author":"Duncan","year":"2012","journal-title":"Cost Eff Resour Allocation"},{"issue":"4","key":"10.1016\/j.vaccine.2016.08.085_b0035","first-page":"615","article-title":"Strategies for improving influenza immunization rates among hard-to-reach populations","volume":"84","author":"Vlahov","year":"2007","journal-title":"NYAM"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.085_b0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1331\/154434503321831120","article-title":"Determinants of adult influenza and pneumonia immunization rates","volume":"43","author":"Kamal","year":"2003","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.vaccine.2016.08.085_b0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.vaccine.2012.11.033","article-title":"The first national adult immunization summit 2012: implementing change through action","volume":"31","author":"Shen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.085_b0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1331\/154434506776180621","article-title":"Pharmacist involvement with immunizations: a decade of professional advancement","volume":"46","author":"Hogue","year":"2006","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.vaccine.2016.08.085_b0055","unstructured":"Bowles S. Role of the pharmacist in the provision of immunization services. <http:\/\/www.google.ca\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=8&ved=0CFsQFjAH&url=http%3A%2F%2Fmicrobiology.mtsinai.on.ca%2Feducation%2FpdfFiles%2FBowles_immunizationroundtable.pdf&ei=tSUSUtr-HcmL2AWUn4GACg&usg=AFQjCNG78QPPRCbTDarg1rB7FJzXZh595w&sig2=YCOHzI6RO3D41dGnuqaznQ&bvm=bv.50768961,d.b2I>; 2005 [accessed 13.08.19]."},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.085_b0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1331\/JAPhA.2008.08508","article-title":"Seasonal and pandemic influenza: preparing pharmacists for the frontline","volume":"48","author":"Klepser","year":"2008","journal-title":"J Am Pharm Assoc"},{"issue":"9","key":"10.1016\/j.vaccine.2016.08.085_b0065","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1345\/aph.1E456","article-title":"Pharmaceutical care in community pharmacies: practice and research in Canada","volume":"39","author":"Jones","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.vaccine.2016.08.085_b0070","unstructured":"American Pharmacists Association. Guidelines for pharmacy-based immunization advocacy. <http:\/\/www.pharmacist.com\/guidelines-pharmacy-based-immunization-advocacy>; 1997 [accessed 13.08.18]."},{"issue":"14","key":"10.1016\/j.vaccine.2016.08.085_b0075","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1503\/cmaj.121990","article-title":"The expanding scope of pharmacists\u2019 practice: implications for physicians","volume":"185","author":"Tannenbaum","year":"2013","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.085_b0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2011.05.008","article-title":"Development of the RTI item bank on risk of bias and precision of observational studies","volume":"65","author":"Viswanathan","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2016.08.085_b0085","unstructured":"Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration; 2011; Available at: <www.cochrane-handbook.org> [accessed 21.11.2014]."},{"issue":"11","key":"10.1016\/j.vaccine.2016.08.085_b0090","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/sim.4780101105","article-title":"A general parametric approach to the meta-analysis of randomised clinical trials","volume":"10","author":"Whitehead","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2016.08.085_b0095","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org [accessed 21.11.2014]."},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.085_b0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.vaccine.2016.08.085_b0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.2042-7174.1993.tb00710.x","article-title":"Community pharmacists as immunization advocates: a pharmacoepidemiologic experiment","volume":"2","author":"Grabenstein","year":"1993","journal-title":"Int J Pharm Pract"},{"issue":"9","key":"10.1016\/j.vaccine.2016.08.085_b0110","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1248\/yakushi.129.1063","article-title":"Impact of community pharmacists advocating immunization on influenza vaccination rates among the elderly","volume":"129","author":"Usami","year":"2009","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.vaccine.2016.08.085_b0115","unstructured":"Cunningham RJ; Brigham and Women\u2019s Hospital. The impact of pharmacist recommendations on quality of care in diabetic patients. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-[cited 2014 Nov 23]. Available from: <http:\/\/clinicaltrials.gov\/show\/NCT00122421> NLM Identifier: NCT00122421 [accessed 23.11.2014]."},{"key":"10.1016\/j.vaccine.2016.08.085_b0120","unstructured":"Rabi SM. Impact of pharmacist pneumococcal vaccination requests for hospitalized patients. ASHP Midyear Clinical Meeting 2006; 41(Dec)."},{"issue":"4","key":"10.1016\/j.vaccine.2016.08.085_b0125","first-page":"270","article-title":"Impact on vaccination rates of a pharmacist-initiated influenza and pneumococcal vaccination program","volume":"53","author":"Ginson","year":"2000","journal-title":"Can J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.085_b0130","first-page":"223","article-title":"Community pharmacist intervention for annual influenza vaccines in a diabetic population","volume":"51","author":"Ellmers","year":"2011","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.085_b0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1331\/JAPhA.2008.07166","article-title":"The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program","volume":"48","author":"Fera","year":"2008","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.085_b0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1592\/phco.26.2.248","article-title":"Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service","volume":"26","author":"McCord","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.vaccine.2016.08.085_b0145","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1592\/phco.21.13.1115.34624","article-title":"Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign","volume":"21","author":"Van Amburgh","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"Dec","key":"10.1016\/j.vaccine.2016.08.085_b0150","first-page":"402","article-title":"Implementation of a pharmacy based pneumococcal vaccination program","volume":"35","author":"Carroll","year":"2000","journal-title":"ASHP Midyear Clinical Meeting"},{"issue":"11","key":"10.1016\/j.vaccine.2016.08.085_b0155","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/502317","article-title":"Improving the rates of inpatient pneumococcal vaccination: impact of standing orders versus computerized reminders to physicians","volume":"25","author":"Coyle","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.085_b0160","first-page":"258","article-title":"Impact of a pharmacy student-based inpatient pneumococcal vaccination program","volume":"65","author":"Dodds","year":"2001","journal-title":"Am J Pharm Educ"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.085_b0165","first-page":"73","article-title":"Pharmacist impact on pneumococcal vaccination rates in long-term-care facilities","volume":"45","author":"Morton","year":"1988","journal-title":"Am J Hosp Pharm"},{"issue":"Dec","key":"10.1016\/j.vaccine.2016.08.085_b0170","article-title":"Interdisciplinary efforts of nurses and pharmacists yield significant improvement in the screening and administering of pneumococcal vaccination","volume":"41","author":"Nyame-Mireku","year":"2006","journal-title":"ASHP Midyear Clinical Meeting"},{"issue":"10","key":"10.1016\/j.vaccine.2016.08.085_b0175","first-page":"1050","article-title":"Pharmacist impact on pneumococcal vaccination rates through incorporation of immunization assessment into critical pathways in an acute care setting","volume":"37","author":"Robke","year":"2007","journal-title":"Hosp Pharm 2002"},{"issue":"14","key":"10.1016\/j.vaccine.2016.08.085_b0180","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/ajhp\/60.14.1471","article-title":"Designing a hospital-based pneumococcal vaccination program","volume":"60","author":"Skledar","year":"2003","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.085_b0185","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1331\/JAPhA.2007.06044","article-title":"Role of student pharmacist interns in hospital-based standing orders pneumococcal vaccination program","volume":"47","author":"Skledar","year":"2007","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"14","key":"10.1016\/j.vaccine.2016.08.085_b0190","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/archinte.158.14.1543","article-title":"A hospital-based pharmacy intervention program for pneumococcal vaccination","volume":"158","author":"Vondracek","year":"1998","journal-title":"Arch Intern Med"},{"issue":"17","key":"10.1016\/j.vaccine.2016.08.085_b0195","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/ajhp\/60.17.1767","article-title":"Effect of a pharmacist-managed program of pneumococcal and influenza immunization on vaccination rates among adult inpatients","volume":"60","author":"Bourdet","year":"2003","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"10.1016\/j.vaccine.2016.08.085_b0200","first-page":"1347","article-title":"Impact of clinical pharmacists on vaccination rates in medicine, surgery, and infectious disease services: a randomized, controlled trial","volume":"22","author":"Dumo","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.085_b0205","doi-asserted-by":"crossref","first-page":"456","DOI":"10.18553\/jmcp.2011.17.6.456","article-title":"Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group","volume":"17","author":"Padiyara","year":"2011","journal-title":"J Manage Care Pharm"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.085_b0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1345\/aph.1Q564","article-title":"Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility","volume":"46","author":"Wallgren","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.vaccine.2016.08.085_b0215","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00005650-200104000-00005","article-title":"Effect of vaccination by community pharmacists among adult prescription recipients","volume":"39","author":"Grabenstein","year":"2001","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.085_b0220","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1331\/JAPhA.2008.07135","article-title":"Establishing an on-site influenza vaccination service in an assisted-living facility","volume":"48","author":"Lam","year":"2008","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.085_b0225","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1592\/phco.27.5.729","article-title":"Pharmacist-managed vaccination program increased influenza vaccination rates in cardiovascular patients enrolled in a secondary prevention lipid clinic","volume":"27","author":"Loughlin","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.085_b0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1715163513514020","article-title":"Pharmacy-based Immunization in Rural Communities Strategy (PhICS): a community cluster-randomized trial","volume":"147","author":"Marra","year":"2014","journal-title":"Can Pharm J (Ott)"},{"issue":"8","key":"10.1016\/j.vaccine.2016.08.085_b0235","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.vaccine.2003.08.045","article-title":"The role of pharmacists in the delivery of influenza vaccinations","volume":"22","author":"Steyer","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.085_b0240","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/ijpp.12037","article-title":"Increasing seasonal influenza vaccination uptake using community pharmacies: experience from the Isle of Wight, England","volume":"21","author":"Warner","year":"2013","journal-title":"Int J Pharm Pract"},{"issue":"45","key":"10.1016\/j.vaccine.2016.08.085_b0245","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1016\/j.vaccine.2011.08.051","article-title":"Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations","volume":"29","author":"Taitel","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.085_b0250","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/1062860612444304","article-title":"A pharmacist visit improves diabetes standards in a patient-centered medical home (PCMH)","volume":"27","author":"Edwards","year":"2012","journal-title":"Am J Med Qual"},{"issue":"8","key":"10.1016\/j.vaccine.2016.08.085_b0255","first-page":"656","article-title":"Treat to goal: impact of clinical pharmacist referral service primarily in diabetes management","volume":"48","author":"Henry","year":"2013","journal-title":"Hosp Pharm 2013"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.085_b0260","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1331\/JAPhA.2012.10083","article-title":"Impact of a pharmacist immunizer on adult immunization rates","volume":"52","author":"Higginbotham","year":"2012","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"9","key":"10.1016\/j.vaccine.2016.08.085_b0265","first-page":"e309","article-title":"Improving pneumococcal and herpes zoster vaccination uptake: expanding pharmacist privileges","volume":"19","author":"Taitel","year":"2013","journal-title":"Am J Manage Care"},{"issue":"4","key":"10.1016\/j.vaccine.2016.08.085_b0270","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.vaccine.2013.11.035","article-title":"Pharmacist-led Tdap vaccination of close contacts of neonates in a women\u2019s hospital","volume":"32","author":"Mills","year":"2014","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2016.08.085_b0275","doi-asserted-by":"crossref","first-page":"832.e1","DOI":"10.1016\/j.amjmed.2013.02.018","article-title":"Improving herpes zoster vaccination rates through use of a clinical pharmacist and a personal health record","volume":"126","author":"Otsuka","year":"2013","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.085_b0280","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1331\/JAPhA.2013.12019","article-title":"Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies","volume":"53","author":"Wang","year":"2013","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.085_b0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3821\/145.2.cpj55c","article-title":"Professionals you can trust: pharmacists top the list again in the Ipsos Reid survey","volume":"145","author":"Lynas","year":"2012","journal-title":"Can Pharm J"},{"issue":"645","key":"10.1016\/j.vaccine.2016.08.085_b0290","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.3399\/bjgp16X684349","article-title":"National community pharmacy NHS influenza vaccination service in Wales: a primary care mixed methods study","volume":"66","author":"Evans","year":"2016","journal-title":"Br J Gen Pract"},{"issue":"2","key":"10.1016\/j.vaccine.2016.08.085_b0295","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11096-016-0255-z","article-title":"Who uses pharmacy for flu vaccinations? Population profiling through a UK pharmacy chain","volume":"38","author":"Anderson","year":"2016","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.085_b0300","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1715163514552557","article-title":"Community pharmacist-administered influenza immunization improves patient access to vaccination","volume":"147","author":"Papasterigiou","year":"2014","journal-title":"Can Pharm J"},{"issue":"5","key":"10.1016\/j.vaccine.2016.08.085_b0305","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1370\/afm.1542","article-title":"Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience","volume":"11","author":"Goad","year":"2013","journal-title":"Ann Fam Med"},{"issue":"6","key":"10.1016\/j.vaccine.2016.08.085_b0310","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/171516350513800606","article-title":"A pilot program of community pharmacy-based influenza immunization clinics","volume":"138","author":"Bowles","year":"2005","journal-title":"Can Pharm J"},{"issue":"Mar","key":"10.1016\/j.vaccine.2016.08.085_b0315","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0895-4356(01)00452-8","article-title":"Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated","volume":"55","author":"Grabenstein","year":"2002","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.08.085_b0320","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1331\/JAPhA.2012.10070","article-title":"Pharmacy provision of influenza vaccinations in medically underserved communities","volume":"52","author":"Murphy","year":"2012","journal-title":"J Am Pharm Assoc"},{"issue":"9","key":"10.1016\/j.vaccine.2016.08.085_b0325","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.vaccine.2015.01.023","article-title":"Impact of influenza vaccination on mortality in the French elderly population during the 2000\u20132009 period","volume":"33","author":"Bonmarin","year":"2015","journal-title":"Vaccine"},{"issue":"47-48","key":"10.1016\/j.vaccine.2016.08.085_b0330","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1016\/j.vaccine.2006.07.042","article-title":"Establishing the health and economic impact of influenza vaccination within the European Union 25 countries","volume":"24","author":"Ryan","year":"2006","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2016.08.085_b0335","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2334-14-76","article-title":"Decline in the incidence of invasive pneumococcal disease at a medical center in Taiwan, 2000\u20132012","volume":"11","author":"Lai","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2016.08.085_b0340","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/003335491412900306","article-title":"Protecting newborns by immunizing family members in a hospital-based vaccine clinic: a successful Tdap cocooning program during the 2010 California pertussis epidemic","volume":"129","author":"Rosenblum","year":"2014","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2016.08.085_b0345","unstructured":"Centre for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months. 2011 Oct 21; 60(41): 1424\u201326."},{"issue":"25","key":"10.1016\/j.vaccine.2016.08.085_b0350","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.vaccine.2015.04.068","article-title":"The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old - Taiwan\u2019s PPV vaccination program","volume":"33","author":"Tsai","year":"2015","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2016.08.085_b0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2334-10-73","article-title":"Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older","volume":"18","author":"Vila-Corcoles","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2016.08.085_b0360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12916-015-0295-6","article-title":"Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis","volume":"17","author":"Remschmidt","year":"2015","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.vaccine.2016.08.085_b0365","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.japh.2016.03.006","article-title":"The impact of pharmacist immunization programs on adult immunization rates: a systematic review and meta-analysis","volume":"56","author":"Baroy","year":"2016","journal-title":"J Am Pharm Assoc (2003)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T18:05:58Z","timestamp":1668621958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16307927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":73,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0264410X16307927"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}